Search Results for: GNK
Shares of IntelliPharmaCeutics soared after the company reported a new licensing deal with Mallinckrodt.
Published:
Last Updated:
Reynolds American Inc. (NYSE: RAI) has an interesting approach in M&A today. The deal is a tiny merger valued at $44 million when you consider that Reynolds has almost a $15 billion market cap,...
Published:
Cinemark Holdings did price its IPO last night at the higher-end of the range. It priced 28 million shares at $19.00, and the range was indicated at $17.00 to $19.00. The joint book...
Published:
Last Updated:
GlaxoSmithKline’s (GSK) diabetes drug Avandia has such frightening side effects that the FDA will probably make it carry a "black box" label. Studies have found that the treatment can...
Published:
A leading diabetes expert says that he wrote the FDA about the heart risks of GSK diabetes drug Avandia. That was seven years ago. More recently, New England Journal of Medicine released a study that...
Published:
GlaxoSmithKline’s (NYSE:GSK) Avandia sales might not just weak after the reports of cardiovascular risks were reported. If this research is accurate, the sales might be on the path to...
Published:
Last Updated:
Kirby Corporation (NYSE: KEX) is signaling that it still has an appetite to find growth. The company is based in Houston and caters to the petrochemicals industries by transporting bulk liquids via...
Published:
Last Updated:
There are several stocks trading more heavily than usual this morning, and also experiencing large gains or drops in share prices. These include Threshold Pharmaceuticals Inc. (NASDAQ: THLD), Zoltek...
Published:
Last Updated:
GlaxoSmithKline (GSK-NYSE) has been under significant pressure of late because of the New England Journal of Medicine showing greatly increased risks of a heart attack for diabetes patients that have...
Published:
Amazon.com posted such strong earnings that its shares soared. Those earnings were dragged down, however, by its troubled international operations.
Published:
Last Updated:
British oil giant BP PLC (NYSE: BP) announced this morning that it has reached a tentative agreement to sell its 50% stake in TNK-BP to Russia’s state-controlled oil company Rosneft for $17.1...
Published:
Theravance Inc. (NASDAQ: THRX) got a big boost today from a purchase of 10 million additional shares by GlaxoSmithKline plc (NYSE: GSK) at a 7.5% premium to a volume-weighted average share price for...
Published:
Pharmacopeia (Nasdaq: PCOP) has announced that it will receive a milestone payment of $5 million from GlaxoSmithKline (NYSE: GSK), bringing the total received to over $16 million in connection with...
Published:
Source: Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall St. research firms this Tuesday.Ameriprise Financial Inc. (NYSE: AMP) cut to Neutral at Credit...
Published:
Last Updated:
GNC saw its shares dip early on Monday after the firm announced that it would be exploring strategic alternatives, just three months after it took on a new CEO.
Published:
Last Updated: